Coverage Database At Tufts Medical Center News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Payers have taken a cautious approach to handling rising demand for the pricey new class of drugs known as glucagon-like peptide agnostics, or GLP-1s.

United statesAntonio ciacciaNovo nordisk wegovyTim norfleetUnitedhealth group optumrxCoverage database at tufts medical centerInstitute for clinicalDrug administrationOhio department of educationOhio departmentUnitedhealth groupNovo nordiskEconomic reviewSpecialty drug evidenceCoverage databaseTufts medical